Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print T cell-based HIV vaccine candidate demonstrates positive results
Slashdot It! Slashdot T cell-based HIV vaccine candidate demonstrates positive results
Submit to Reddit Submit T cell-based HIV vaccine candidate demonstrates positive results to Reddit
Reading: T cell-based HIV vaccine candidate demonstrates positive resultsTwitter This Reading: T cell-based HIV vaccine candidate demonstrates positive resultsTwitter T cell-based HIV vaccine candidate demonstrates positive results
Add to Facebook Add T cell-based HIV vaccine candidate demonstrates positive results to Facebook

T cell-based HIV vaccine candidate demonstrates positive results

November 10, 2008

Study demonstrates proof-of-concept for vaccine model

BOSTON -- The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.




Now a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) provides the proof-of-concept that a T-cell-based strategy remains a viable course to follow.

Described in today's dvance On-line Publication of Nature, the study showed that an improved regimen using two distinct adenovirus vectors - rAd26 prime/rAd5 boost - and expressing the simian immunodeficiency virus (SIV) Gag protein, resulted in potent T-cell immune responses leading to long-term immune control of an SIV challenge in monkeys. The findings demonstrate for the first time using this stringent animal model that such a vaccine may be effective in the fight against AIDS.

"This is a controversial field right now," says the study's lead scientist Dan Barouch, MD, PhD, Principal Investigator of the NIH-sponsored Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) program, who is working to develop new HIV-1 vaccine candidates. "Despite the disappointing setbacks in HIV-1 vaccine development this past year, our findings suggest that we're not at the end of the road when it comes to T-cell vaccines. Our data show that T-cell vaccines that elicit greater magnitude, breadth, and quality of immune responses as compared with the Merck vaccine can result in improved protection in the rhesus monkey model of AIDS."

The induction of the immune system's "killer" T-cells as a means of protecting against HIV-1 is designed to overcome a number of unique obstacles that make the virus impervious to traditional vaccine strategies, which typically work by producing antibodies to eliminate the invading virus. Instead, T-cell generated immunity works by selectively targeting and destroying any cells that have already been infected by the virus.

"Although our vaccine regimen did not prevent acquisition of SIV infection, it substantially reduced the levels of virus in the blood of these animals and prevented the development of AIDS," says Barouch, who is also an Associate Professor of Medicine at Harvard Medical School.

Barouch and his colleagues in the Division of Viral Pathogenesis at BIDMC, in collaboration with the biotechnology company Crucell Holland BV, have spent the past three years developing new rare serotype adenoviral vectors, which deliver HIV antigens and are the basis for one strategy of HIV-1 vaccine development. Viral vector vaccines are made by deleting one or more genes from a harmless or attenuated virus, in this case, adenovirus. Segments of DNA-encoding HIV-1 proteins are inserted in place of the deleted genes and thereby transfer the proteins into human cells to stimulate an immune response to the HIV-1 virus.

Last year's Merck trial used as its vector adenovirus serotype 5 (rAd5) which is a virus responsible for the common cold. "Because Ad5 is encountered frequently in the environment," explains Barouch, "many individuals harbor preexisting immunity to this virus." As a result, following vaccination, this vector often proves ineffective in delivering its "cargo" to induce an immune response to HIV.

In the new study, Barouch's laboratory used an rAd26 viral vector as its means of transport. Ad26 is rarely encountered in the human population and has the ability to induce a potent immune response, providing protective efficacy against SIV.

Also distinct from the Merck study, the authors made use of a heterologous "prime-boost" system to enhance the vaccine's immunogenicity. "In most cases, the immune response induced by a single dose of a vaccine isn't strong enough or sustainable enough to provide effective protection," explains Barouch. By administering a second "boost" the antigen's immune response can be enhanced. In this case, the scientists successively administered the same antigen in two separate vectors: The first rAd26 vector "primed" the animals' immune responses; re-exposure to the same antigen in a second rAd5 vector provided the "boost."

Their results showed that when challenged with a lethal dose of SIV, the vaccinated animals were able to reduce viral replication and to remain healthy for more than 500 days following infection, indicating that the vaccine had sparked a powerful immune response.

"This is an extremely important study because it shows that there is still hope for vaccines currently in the pipeline," says Bruce Walker, MD, Director of the Harvard University Center for AIDS Research (CFAR). "It also gives the first clear indication of the level and type of immunity that will likely be needed for an AIDS vaccine to work."

More than 25 years after the discovery of HIV-1, AIDS remains one of the world's most devastating health problems. An estimated 33.2 million people currently live with HIV/AIDS while 2.5 million new infections were reported in 2007 alone.

Beth Israel Deaconess Medical Center





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Bacteria   Polio   Down syndrome   Modern Human   Hydrogen Fuel   Superconductors   Chewing Gum   Embryonic Development   Blood-brain Barrier   Anxiety disorder   Anorexia   Sexual Selection   Neurodegeneration   Loneliness   Meditation   Gastric Bypass   Pathogen   Drug Delivery   Chronic Infection   Colon Cancer   Sepsis   Ptsd   Botox   Space Telescope   Protons  
Related Immune Response Current Events and Immune Response News Articles Immune Response Current Events and Immune Response News RSS Immune Response Current Events and Immune Response News RSS
UCLA collaboration identifies immune system link to schizophrenia
Schizophrenia is a devastating mental disease, thought to be caused by the interaction of both genetic and environmental factors.

Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection.

Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme.

Plant protein 'doorkeepers' block invading microbes, study finds
A group of plant proteins that "shut the door" on bacteria that would otherwise infect the plant's leaves has been identified for the first time by a team of researchers in Denmark, at the University of California, Davis, and at UC Berkeley.

MicroRNAs help control HIV life cycle
Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specific microRNAs (non-coding RNAs that interfere with gene expression) reduce HIV replication and infectivity in human T-cells.

Like burrs on your clothes, molecule-size capsules can deliver drugs by sticking to targeted cells
It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials with almost 100 percent efficiency to targeted cells in the bloodstream.

Inflammation markers linked more with fatal than nonfatal cardiovascular events in elderly
A study published this week in the open access journal PLoS Medicine shows that for elderly people at risk of cardiovascular disease, the presence of inflammatory markers in the blood can identify that an individual is at a higher risk of a fatal rather than a non-fatal heart attack or stroke.

A urine test for appendicitis?
Appendicitis is the most common childhood surgical emergency, but the diagnosis can be challenging, especially in children, often leading to either unnecessary surgery in children without appendicitis, or a ruptured appendix and serious complications when the condition is missed.

Transplant drug stimulates immune memory
Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered.

Statins can protect against Alzheimer's disease, according to new study
High cholesterol levels are considered to be a risk factor not only for cardiovascular disease including stroke, but also for the development of Alzheimer's disease.
More Immune Response Current Events and Immune Response News Articles
Primer to The Immune Response

Primer to The Immune Response
by Tak W. Mak (Author), Mary Saunders (Author)

Primer to The Immune Response is an invaluable resource for college students, university undergraduates and students in medicine and other health professions who need a concise but complete and understandable introduction to immunology.
This book is written in the same engaging conversational style as the published reference book The Immune Response: Basic and Clinical Principles and conveys the same fascinating appeal of immunology. The authors bring clarity, readability and continuity of voice to an audience that requires only a brief survey of the most fundamental concepts in basic and clinical immunology. Primer to The Immune Response is beautifully illustrated with over 200 superb figures and 36 full color plates, and further enhanced by the inclusion of 60 tables and 6...

  Bacterial Evasion of Host Immune Responses
by Cambridge University Press

Over the past fifty years cells and mediators involved in our immune defences have been painstakingly identified. However, it is only relatively recently that the ability of microorganisms to evade immunity has been recognized and investigated. This volume introduces the mechanisms used by bacteria to evade both humoral and cellular immune responses, using systems ranging in complexity from the simple quorum sensing molecules (acyl homoserine lactones) to the supramolecular syringe-like devices of type III secretion systems.

Michael's Health Products - Quick Immune Response, 60 tablets

Michael's Health Products - Quick Immune Response, 60 tablets
by Michael's Health Products



Source Naturals Aller-Response, Tablets, 90 tablets (Pack of 2)

Source Naturals Aller-Response, Tablets, 90 tablets (Pack of 2)
by Source Naturals

Dietary supplement. Quercetin, Ginkgo & Synephrine. Aller-Response is a seasonal formula featuring quercetin. Human cell culture studies with quercetin demonstrated its capability to inhibit the release of histamines. Ginkgolide B, in human cell culture s

The Immune Response: Basic and Clinical Principles

The Immune Response: Basic and Clinical Principles
by Tak W. Mak (Author), Mary Saunders (Author)

The Immune Response is a unique reference work covering the basic and clinical principles of immunology in a modern and comprehensive fashion. Written in an engaging conversational style, the book conveys the broad scope and fascinating appeal of immunology. The book is beautifully illustrated with superb figures as well as many full color plates. This extraordinary work will be an invaluable resource for lecturers and graduate students in immunology, as well as a vital reference for research scientists and clinicians studying related areas in the life and medical sciences.

* Current and thorough 30 chapter reference reviewed by luminaries in the field
* Unique 'single voice' ensures consistency of definitions and concepts
*...

Molecular Mechanisms of Immune Responses in Insects

Molecular Mechanisms of Immune Responses in Insects
by Springer

Insects are the most numerous and diverse group of animals on earth, not only in number of individuals, but also in number of species. They inhabit virtually all terrestrial and freshwater environments, where they must protect themselves from an array of commensal, pathogenic and parasitic organisms that share the same ecological niches. Since the early 20th century, scientists have been intrigued by how insects defend themselves against microbial attack. We are currently witnessing a break-through in our understanding of the mechanisms governing immune reactions in insects. Molecular Mechanisms of Immune Responses in Insects covers various aspects of these mechanisms starting with a historical chapter on the origins of insect immunity. There are also chapters that cover...

Vetri-DMG Tablets for Dogs & Cats (90 Tabs)

Vetri-DMG Tablets for Dogs & Cats (90 Tabs)
by vetri science

Recommended to help support proper immune response, cardiovascular and skin health, glucose metabolism and proper nerve and brain functions.

Metabolic Maintenance L-Glutamine 500 mg 100 caps

Metabolic Maintenance L-Glutamine 500 mg 100 caps
by Metabolic Maintenance

L-Glutamine 500 mg 100 caps

The Human Body: How We Fail, How We Heal - DVD - The Teaching Company

The Human Body: How We Fail, How We Heal - DVD - The Teaching Company
by The Teaching Company

Your body is a fortress under constant assault. Infectious diseases, parasites, environmental toxins, physical trauma, allergens, and natural disasters are some external enemies it faces. From the inside, it is threatened by occasional overzealous allergic, immune, and inflammatory responses, as well as by the cellular mutations that produce cancer. Fortunately, the body's defenses are remarkably successful, and most of the time we are unaware of the intense drama taking place within our cells and organs. The intriguing details of this drama make up the field of pathophysiologythe study of the disruptions in a normal body's functions that are caused by disease or injury. Medical students get an exhaustive introduction to this subject early in their training, and the best clinicians are...

Bedside Emergencies: Anaphylactic Shock (Volume 3)

Bedside Emergencies: Anaphylactic Shock (Volume 3)
Also With: Concept Media (Primary Contributor)

Describes the body's normal immune response and how it responds physiologically to allergens. Differentiates between anaphylactic and anaphylactoid reactions, describing signs and symptoms. Describes initial interventions to slow down or prevent reaction from becoming life-threatening, as well as more aggressive therapy for severe, progressive reactions.

© 2009 BrightSurf.com